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Summary
Myxococcus xanthus is a gliding bacterium with a
complex life cycle that includes swarming, predation
and fruiting body formation. Directed movements in
M. xanthus are regulated by the Frz chemosensory
system, which controls cell reversals. The Frz
pathway requires the activity of FrzCD, a cytoplasmic
methyl-accepting chemotaxis protein, and FrzF, a
methyltransferase (CheR) containing an additional
domain with three tetra trico-peptide repeats (TPRs).
To investigate the role of the TPRs in FrzCD methyla-
tion, we used full-length FrzF and FrzF lacking its
TPRs (FrzFCheR) to methylate FrzCD in vitro. FrzF
methylated FrzCD on a single residue, E182, while
FrzFCheR methylated FrzCD on three residues, E168,
E175 and E182, indicating that the TPRs regulate site-
speciﬁc methylation. E168 and E182 were predicted
consensus methylation sites, but E175 is methylated
on an HE pair. To determine the roles of these sites
in vivo, we substituted each methylatable glutamate
with either an aspartate or an alanine residue and
determined the impact of the point mutants on single
cell reversals, swarming and fruiting body formation.
Single, double and triple methylation site mutants
revealed that each site played a unique role in
M. xanthus behaviour and that the pattern of receptor
methylation determined receptor activity. This work
also shows that methylation can both activate and
inactivate the receptor.
Introduction
Myxococcus xanthus is a Gram-negative bacterium that
hasacomplexlifecyclethatinvolvesvegetativeswarming,
predation and fruiting body formation (Reichenbach, 1999;
Shimkets, 1999; Kaiser, 2003; 2004; Berleman et al.,
2006).These behaviours require motility on solid surfaces:
S-motility powered by Type IV pili (Wu and Kaiser, 1995)
moves cells in groups and A-motility powered by unidenti-
ﬁed motor proteins and putative adhesion complexes
moves single cells (Mignot, 2007). To achieve directed
movements, M. xanthus cells periodically reverse so that
the leading pole becomes the lagging pole. The frequency
of cell reversals is controlled by the frz chemosensory
pathway and is important for directed cell movements
(Blackhart and Zusman, 1985). frz mutants (DfrzA, DfrzB,
DfrzCD, DfrzE, DfrzF) rarely reverse and are therefore
defective in swarming and fruiting body formation, forming
frizzy aggregates instead of fruiting bodies on starvation
media (Zusman, 1982). In contrast, some constitutively
signallingfrzmutantshyper-reverse,formingverycompact
colonies with little cell spreading (Blackhart and Zusman,
1985; Bustamante et al., 2004).
Frz proteins are homologous to bacterial chemotaxis
proteins (McBride et al., 1989; Zusman et al., 2007).
FrzCD, a cytoplasmic methyl-accepting chemotaxis
protein (MCP) homologue, lacks the transmembrane and
periplasmic domains common to most MCPs and has in
its place a unique N-terminal domain. In contrast, the
C-terminal domain of FrzCD is similar to other MCPs and
contains potential methylation sites (Astling et al., 2006).
In vitro analysis has shown that FrzCD interacts with FrzE,
a histidine kinase (CheA)-response regulator fusion
protein by means of two CheW-like proteins, FrzA and
FrzB (Astling, 2003). When stimulated, FrzE autophos-
phorylates and transfers a phosphoryl group to the dual
response regulator FrzZ, triggering cell reversals for both
the A- and S-motility systems (Inclán et al., 2007).
It is not known how FrzCD receives signals as it lacks
the usual signal-binding domain common to most MCPs.
Furthermore, frzCD N-terminal domain deletion mutants
show only minor defects in behaviour (Bustamante et al.,
2004). Previously, it was hypothesized that a signal input
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of particular sites on the receptor (Igoshin et al., 2004;
Astling et al., 2006). Astling et al. (2006) identiﬁed several
putative methylation sites based on sequence in compari-
son with known Escherichia coli methylation sites. They
systematically mutated these sites, substituting each EE,
QQ, QE and EQ pair with an alanine pair (AA). This work
suggested that FrzCD receptor activity could be turned on
or off depending on the site that was methylated.
Based on this work, we hypothesized that differential
methylation of FrzCD may be mediated by FrzF, a methyl-
transferase (CheR) homologue (McCleary et al., 1990)
that contains an additional domain with three tetra trico-
peptide repeats (TPRs) (Shiomi et al., 2002). In other
organisms, TPRs have been shown to mediate protein–
protein interactions (Blatch and Lassle, 1999). A Basic
LocalAlignment SearchTool (BLAST) (Altschul et al., 1990)
analysis of all sequenced bacterial genomes revealed that
dozens of bacterial species possess putative methyltrans-
ferases with one or more TPRs, including several within
the a-proteobacteria, b-proteobacteria, d-proteobacteria
and high GC-rich Gram-positive bacteria. In M. xanthus,
CheR4 and CheR6 are each predicted to contain one TPR
(Scott, 2008). However, to our knowledge, no function has
yet been attributed to TPRs in methyltransferases.
To investigate the role of the TPR containing domain in
FrzCD methylation, we used full-length FrzF and FrzF
lacking the TPRs (FrzFCheR) to methylate FrzCD in vitro.
We found that indeed the TPRs of FrzF negatively regu-
late FrzCD methylation. We used mass spectrometry to
identify the methylated sites and site-directed mutagen-
esis to determine the function of these sites in vivo. This
work showed that each FrzCD methylation site played
speciﬁc roles in cell motility and behaviour.
Results
Methylation of FrzCD in vitro using puriﬁed FrzF
and FrzFCheR
Previous work showed that methylation of FrzCD is
required for swarming and fruiting body formation in
M. xanthus and that methylation is mediated by FrzF
(McBride et al., 1989; McCleary et al., 1990). FrzF is a
complex methyltransferase that contains an N-terminal
domain with 31% sequence identity (83 of 271 amino
acids) to the methyltransferase (CheR) of E. coli and a
C-terminal domain with three TPRs (Fig. 1A). Because of
its high homology to CheR, the N-terminal domain of FrzF
was assumed to have methyltransferase activity, but the
Fig. 1. Methylation of FrzCD by FrzF and
FrzF
CheR in vitro.
A. Cartoons show the domain organization of
the wild-type FrzF protein and the FrzF
CheR
protein, which lacks FrzF amino acids
450–580. TPR indicates a tetra-trico peptide
repeat. Numbers refer to the amino acid
position in full-length FrzF.
B. His-tagged FrzCD was expressed and
puriﬁed from E. coli and incubated in vitro with
puriﬁed FrzF or FrzF
CheR and S-adenosyl
methionine (SAM) for 4 h at 32°C. Following
the reaction, FrzCD was analysed by
SDS-PAGE and Western immunoblotting
using puriﬁed a-FrzCD antibodies. The
white arrowhead shows the mobility of
unmethylated FrzCD; the black arrowheads
indicate methylated FrzCD. The position of
the molecular weight markers is indicated on
the left.
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mine the activities of full-length FrzF and FrzFCheR (FrzF
lacking its TPR domains), we cloned His-tagged frzCD,
frzF and frzF CheR in expression vectors and puriﬁed the
respective proteins from E. coli. FrzCD puriﬁed from
E. coli was unmethylated (Fig. 1B, lane 3), indicating that
the E. coli methyltransferase does not methylate FrzCD.
To methylate FrzCD in vitro, we incubated FrzCD and the
methyl donor S-adenosyl methionine (SAM) with either
FrzF or FrzFCheR. The reactions were monitored by
Western immunoblot analysis using puriﬁed anti-FrzCD
antibodies as methylated FrzCD migrates faster than
unmethylated FrzCD in this SDS-PAGE system
(McCleary et al., 1990). We found that that both FrzF and
FrzFCheR were able to methylate FrzCD in the presence of
SAM (Fig. 1B), but that they produced different FrzCD
methylation patterns. FrzFCheR produced a faster migrating
band of FrzCD (Fig. 1 lane 5) than FrzF (Fig. 1 lane 4).
Neither FrzF nor FrzFCheR were able to methylate FrzCD
without SAM (data not shown). As methylated receptors
migrate faster than unmethylated receptors in this gel
system, we hypothesized that the faster migrating band
observed with the FrzFCheR sample represented a more
methylated species of FrzCD.
Identifying the methylated residues of FrzCD
As the mobility of FrzCD on polyacrylamide gels does not
give us quantitative data on methylation patterns, we
analysed the in vitro methylated FrzCD by mass spec-
trometry. We prepared methylated FrzCD samples as
described above by incubating puriﬁed FrzCD, SAM and
either FrzF or FrzFCheR; as a control, we also prepared
non-methylated FrzCD in the same way except that we
omitted FrzF. To generate peptides of the optimal size for
mass spectrometry, we digested the methylated and unm-
ethylated FrzCD samples with trypsin, chymotrypsin or
GluC proteases. The combined tandem mass spectrom-
etry (MS/MS) results accounted for 92.3% total sequence
coverage including 100% sequence coverage of the
C-terminus of FrzCD (amino acids 136–437), predicted to
contain all putative methylation sites (Fig. S1).
A comparison between spectra of tryptic FrzCD pep-
tides methylated by FrzF and by FrzFCheR revealed that
FrzF methylated FrzCD on a single glutamate residue
and that FrzFCheR methylated FrzCD on three residues
(based on accurate precursor mass measurement and
MS/MS data) within the peptide L148-K184. This peptide
sequence includes ﬁve glutamate residues, all represent-
ing possible sites of methylation. However, while fragmen-
tation was sufficient for the identiﬁcation of the peptide, as
well as the presence of methylation, it was not adequate
to obtain the sequence coverage necessary to ascertain
the speciﬁc sites of methylation (data not shown). To
address this, FrzCD was digested with the chymotrypsin
and GluC proteases. Chymotrypsin allowed us to deter-
mine that FrzCD was methylated by FrzF on E182
(Table 1, Fig. S2). Speciﬁcally, the b-ion with the value of
1372.3 indicates that there is a methylated glutamate on
the N-terminal side of residue L183 and the b-ion with the
value of 1301.1 indicates that no residue is methylated to
the N-terminal side of E182. Thus, the only residue that
can be methylated on this peptide is E182. However, we
found that the peptides were not always methylated.
For instance, two of the nine 157AASTQHETSSTEQAAA
IHETTATMEEL183 peptides analysed showed methylation
on site E182 (Table 1, Fig. S2, and data not shown). No
methylation was seen on sites E168 or E175 on any of the
nine peptides. MASCOT scores for these nine peptides
were all greater than 24 indicating that these results are
highly signiﬁcant.
We found that FrzFCheR methylated FrzCD on residues
E175 and E182 by using a chymotrypsin digest (Table 2,
Fig. S3A). Speciﬁcally, b-ion 849.7 showed that the
methylated glutamate was on the C-terminal side of
residue I173 and b-ion 1040.6 showed that the methy-
lated glutamate was on the N-terminal side of T176. Thus,
E175 must be methylated as it is the only glutamate
between residues I173 and T176. b-ion 1315.2 showed
that another methylated glutamate was located on the
Table 1. Ions from MS/MS spectrum of a chymotryptic fragment
a of
FrzCD show FrzF methylates site E182.
AA
b
Theoretical
c
b-ions
d
Observed
e
b-ions
Theoretical
y-ions
f
Observed
y-ions
I173 842.9 (2+) 843.0 (2+)
H174
E175
T176 1026.5 (2+) 1026.3 (2+)
T177 824.4 824.0
A178 1112.5 (2+) 1112.5 (2+) 723.3 723.1
T179 1163.0 (2+) 1163.0 (2+) 652.3 652.1
M180 1236.6 (2+) 1236.9 (2+) 551.2 551.1
E181 1301.1 (2+) 1301.0 (2+)
E182# 1372.6 (2+) 1372.3 (2+)
L183
a. No ions were observed for residues 157AASTQHETSSTEQA
AA172 of the chymotryptic peptide 157AASTQHETSSTEQAAAIHET
TATMEEL183 (Fig. S2), so these residues were removed from the left
column for simplicity.
b. Amino acids are indicated by their one letter code; numbers rep-
resent their position in FrzCD. The # symbol represents an amino acid
that is methylated.
c. Theoretical ions are calculated by dividing the predicted mass of
an ion by the ion’s charge, m/z = (M + nH
+)/n.
d. A b-ion is an N-terminal charged fragment generated after ion
activation causes a peptide bond to break.
e. Observed ions were found by digesting FrzCD with chymotrypsin
and using tandem MS/MS.
f. A y-ion is a C-terminal charged fragment generated after ion acti-
vation causes a peptide bond to break.
All ions are 1+ charged unless otherwise indicated in parentheses.
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site of methylation (Table 2, Fig. S3A). Similar to our FrzF
data, we found that the FrzFCheR methylated FrzCD pep-
tides were not always fully methylated. For instance, one
of the three 157AASTQHETSSTEQA AAIHETTATMEEL183
peptides analysed showed methylation on sites E175 and
E182 (Table 2, Fig. S3A). The remaining two peptides
showed methylation only on site E182 (Data not shown).
MASCOT scores for these three peptides were all greater
than 24 indicating that these results are highly signiﬁcant.
To ﬁnd the third site methylated by FrzFCheR, we used a
GluC digest (Table 3, Fig. S3B). The b-ion 648.2 showed
that a glutamate was methylated on the N-terminal site of
Q169 and the y-ion 1546.4 showed that a glutamate was
methylated on the C-terminal side of T167. In all seven
164TSSTEQAAAIHE175 peptides analysed, site E168 was
shown to be methylated (data not shown). In one out of
four the 164TSSTEQAAAIHETTATME181 peptides analy-
sed, both E168 and E175 were found to be methylated
(Fig. S3B). In all eight of the 169QAAAIHETTATME181
peptides site E175 was methylated (data not shown).
MASCOT scores for these peptides were all greater than
24 indicating that these results are highly signiﬁcant.
The sample without FrzF was not methylated at any site
(Table S1, Fig. S4, and data not shown). None of the 14
copiesofthe 157AASTQHETSSTEQAAAIHETTATMEEL183
peptide showed methylation (Table S1 and Fig. S2).
MASCOT scores for these 14 peptides were all greater
than 24 indicating that these results are highly signiﬁcant.
In summary, mass spectrometry showed that in vitro
FrzF methylates FrzCD on one site (E182) and that
FrzFCheR methylates FrzCD on three sites (E168, E175 and
E182). This would suggest that the TPR domain of FrzCD
is a regulatory domain that inhibits the methyltransferase
activity of FrzF at two speciﬁc sites, E168 and E175.
Isolation and characterization of methylation
site point mutants
To learn the function of these three FrzCD methylation
sites, we constructed FrzCD methylation point mutants
where we replaced a methylatable glutamate residue with
either an aspartate or an alanine residue. These substi-
tutions have been used in other bacteria to mimic
unmethylated and methylated glutamates, respectively,
as aspartate residues, which cannot be methylated, main-
tain the negative charge of a glutamate residue and
alanine residues are neutrally charged, similar to methy-
lated glutamates (Nowlin et al., 1988; Park et al., 1990;
Shapiro and Koshland, 1994).
FrzCD methylation site point mutants were generated
by PCR, cloned into the plasmid pCT2, and integrated into
Table 2. Ions from a MS/MS spectrum of a chymotryptic fragment
a
of FrzCD show FrzF
CheR methylates sites E175 and E182.
AA
b
Theoretical
c
b-ions
d
Observed
e
b-ions
Theoretical
y-ions
f
Observed
y-ions
I173 849.9 (2+) 849.7 (2+)
H174
E175#
T176 1040.5 (2+) 1040.6 (2+)
T177 1091.0 1091.4 824.4 824.2
A178 1126.5 (2+) 1126.6 (2+) 723.3 722.9
T179 1177.0 (2+) 1177.1 (2+) 652.3 652.0
M180 1250.6 (2+) 1251.0 (2+) 551.2 551.0
E181 1315.1 (2+) 1315.2 (2+)
E182# 1372.6 (2+) 1372.3 (2+)
a. No ions were observed for residues 157AASTQHETSSTEQA
AA172 of the chymotryptic peptide 157AASTQHETSSTEQAAAIHET
TATMEEL183 (Fig. S3A), so these residues were removed from the left
column for simplicity.
b. Amino acids are indicated by their one letter code; numbers rep-
resent their position in FrzCD. The # symbol represents an amino acid
that is methylated.
c. Theoretical ions are calculated by dividing the predicted mass of
an ion by the ion’s charge, m/z = (M + nH
+)/n.
d. A b-ion is an N-terminal charged fragment generated after ion
activation causes a peptide bond to break.
e. Observed ions were found by digesting FrzCD with chymotrypsin
and using tandem MS/MS.
f. A y-ion is a C-terminal charged fragment generated after ion acti-
vation causes a peptide bond to break.
All ions are 1+ charged unless otherwise indicated in parentheses.
Table 3. Ions from an MS/MS spectrum of a GluC digested frag-
ment
a show FrzF
CheR methylates FrzCD on sites E168 and E175.
AA
b
Theoretical
c
b-ions
d
Observed
e
b-ions
Theoretical
y-ions
f
Observed
y-ions
E168 1546.7 1546.4
Q169 648.3 648.2 1403.6 1403.4
A170 719.3 719.2 1275.6 1275.3
A171 1204.6 1204.4
A172 861.4 861.2 1133.5 1133.3
I173 974.5 974.3 1062.5 1062.3
H174 1111.5 1111.3 949.4 949.3
E175# 1254.6 1255.3
T176 1355.6 1355.4 669.3 669.1
T177 1456.7 1456.4 568.2 568.1
A178 1527.7 1527.5 467.2 467.1
T179 1628.8 1628.5 396.1 396.1
M180 295.1 295.1
a. No ions were observed for residues 164TSST167 of the GluC-
generated fragment 164TSSTEQAAAIHETTATME181 (Fig. S3B), so
these residues were removed from the left column for simplicity.
b. Amino acids are indicated by their one-letter code; numbers rep-
resent their position in FrzCD. The # symbol represents an amino acid
that is methylated.
c. Theoretical ions are calculated by dividing the predicted mass of
an ion by the ion’s charge, m/z = (M + nH
+)/n.
d. A b-ion is an N-terminal charged fragment generated after ion
activation causes a peptide bond to break.
e. Observed ions were found by digesting FrzCD with chymotrypsin
and using tandem MS/MS.
f. A y-ion is a C-terminal charged fragment generated after ion acti-
vation causes a peptide bond to break.
All ions are 1+ charged.
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strain. We expressed frzCD under control of the tet pro-
moter by growing cells in the presence of anhydrotetra-
cycline (Mignot et al., 2007). As a positive control we
made strain DZ4717, which contains the non-mutated
frzCD gene in the crtB locus under the control of the tet
promoter. We found that DZ4717 displayed phenotypes
that were comparable to that of the wild-type strain, DZ2
(Fig. S5). To ensure that all strains expressed the FrzCD
protein, we examined each strain by immunoblot analysis
using the anti-FrzCD antibody. Figure 2 shows that FrzCD
was expressed at the same level in all strains and that any
changes in phenotype were not due to altered expression.
We then determined the effects of mutating the methy-
lation sites on M. xanthus fruiting body formation (Fig. 3)
and swarming (Fig. 4), phenotypes that require a function-
ing Frz pathway. For reference, we also examined the
phenotypes of the hypo-reversing DfrzCD mutant and the
Fig. 2. FrzCD methylation point mutants
are stably expressed. An immunuoblot of
vegetative cell extracts from the methylation
point mutants probed with the a-FrzCD
antibody. Thirty micrograms of total protein
from whole cell extracts were loaded per lane.
The white arrowhead shows the mobility of
unmethylated FrzCD; the black arrowhead
indicates methylated FrzCD. DZ4717
(6His::frzCD) is the positive control strain
used in this study. All point mutations were
made in the DZ4717 background.
frzCD
DZ4717
frzCD E168A
frzCD E168D
frzCD E175A
frzCD E175D
frzCD E182A
frzCD E182D
frzCD E168A E175A
frzCD E168D,E175D
frzCD E168A E175A,E182A
frzCD E168D,E175D,E182D
54Kd
Fig. 3. Effect of FrzCD E to A and E to D
methylation site mutations on aggregation and
fruiting body formation. FrzCD methylation
site glutamates (E) 168, 175 and 182 were
changed to alanine (A) or aspartate (D)
residues by site directed mutagenesis as
described in Experimental procedures. Cells
were spotted at 4 ¥ 10
9 cells ml
-1 on CF
fruiting agar and incubated for 4 days at 32°C.
Reference strains (DZ4717 (6His::frzCD),
DfrzCD, and frzCDD6
-183) are shown in A–C.
FrzCD E to A mutants are shown in the
middle column (D, F, H, J and L) and FrzCD
E to D mutants are shown in the right column
(E, G, I, K and M). The small corner inset in
each picture is a 7 ¥ magniﬁcation of a
portion of the original.
Δ
Δ B frzCD
A DZ4717
C frzCD 6-183
D Site 168
F Site 175 G Site 175
H Site 182 I Site 182
K Sites 168+175
L Sites 168+175+182 M Sites 168+175+182
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(Bustamante et al., 2004), the DfrzCD control strain exhib-
ited reduced swarming on rich media, formed tangled
aggregates instead of fruiting bodies on starvation media,
and reversed infrequently. In contrast, the frzCD D6–183
control strain did not swarm on rich media, was unable to
form aggregates on starvation media, and reversed much
more frequently as single cells than wild type (Figs 3 and
4; Table 4). The methylation point mutants displayed
varied phenotypes: some behaved like wild type, whereas
others displayed DfrzCD, frzCD D6–183 or intermediate
phenotypes.
(i) The most severe single mutant phenotypes were
observed when we eliminated methylation at E182.
The frzCD E182D mutant, similar to DfrzCD, showed
reduced swarming (Fig. 4), formed tangled aggregates
instead of fruiting bodies (Fig. 3I), and had a severely
reduced single cell reversal frequency when compared
with DZ4717 (Table 4). The frzCD E182A mutant dis-
played an intermediate swarming phenotype between
DZ4717 and the frzCD E182D mutant (Fig. 4), was able
to form fruiting bodies (Fig. 3H), but still showed a
reduced single cell reversal frequency (Table 4). Thus,
FrzCD methylation site 182 is important for both social
behaviours and single cell reversals.
(ii) Single mutations in E175 or E168 resulted in less
severe defects than single mutations in site E182. E to
A or E to D mutations at site 175 allowed cells to
swarm like DZ4717 (Fig. 4) and to form fruiting bodies
(Figs 3F,G). Yet both of these mutants showed a
decrease in reversal frequency when compared with
DZ4717 (Table 4). The frzCD E168D mutant displayed no
obvious defects. While the frzCD E168A mutant dis-
played a 30% decrease in swarming (Fig. 4), it showed
normal single cell and fruiting body behaviour. Thus,
site E175 is required for single cell reversal frequency,
but neither site E168 nor E175 must be methylated for
proper fruiting body formation.
In E. coli, methylation site mutants display additive phe-
notypes; defects increase in severity as additional methy-
lation sites are mutated (Shapiro et al., 1995). To test if
methylation site mutations resulted in additive defects in
M. xanthus, we constructed double and triple methylation
site point mutants. We expected the double and triple
mutants to display more severe defects than the single
mutants. However, we found that the frzCD E168D,E175D and
frzCD E168D,E175D,E182D mutants displayed DZ4717 pheno-
types under all conditions tested (Fig. 3K and M, Fig. 4,
Table 4). This was surprising as the frzCD E175D and the
frzCD E182D mutants displayed reduced single cell reversal
frequencies compared with DZ4717. These results
suggest that the overall number of methylatable FrzCD
residues is not crucial, but rather the pattern of FrzCD
methylation is the determining factor for receptor function.
We were also surprised to ﬁnd that the frzCD E168A,E175A
and frzCD E168A,E175A,E182A mutants displayed severe
defects under all conditions tested, as the single site
Fig. 4. Effect of FrzCD E to A and E to D
methylation site mutations on vegetative
swarming. Reference strains [DZ4717
(6His::frzCD), DfrzCD and frzCD
D6–183] are
shown at the top (striped bars), FrzCD E to A
mutants are shown in the left panel (dark
grey), and FrzCD E to D mutants are shown
in the right panel (light grey). The horizontal
axis represents the relative distance swarmed
by each strain compared with wild type. Error
bars represent the standard deviation of the
mean. Five microlitres of 4 ¥ 10
9 cells ml
-1
were spotted on CYE nutrient plates
containing 0.4% agar and swarm expansion
was measured after 3 days incubation at
32°C. Data shown are from two independent
experiments with a total of seven
measurements per strain.
Sites 168+175+182
Sites 168+175
frzCD 6–182
Site 182
Site 175
Site 168
frzCD
DZ4717
0% 20% 40% 60% 80% 100% 0% 20% 40% 60% 80% 100%
Et oA Et oD
Swarming (% of wild type) Swarming (% of wild type)
Reference
Et oA
Et oD
Table 4. Effect of methylation site mutations on single cell
reversals.
Strain
Average reversals
in 30 min (# cells)
Average reversals in
30 min E to D (# cells)
DZ4717
a 1.58 (84)
DfrzCD 0.20 (59)
frzCDD
6-183 12.14 (24)
Site 168 1.67* (49) 1.57* (74)
Site 175 0.82 (44) 0.25 (58)
Site 182 0.58 (29) 0.22 (34)
Sites 168 + 175 6.25 (70) 1.34* (59)
Sites 168 + 175 + 182 4.63 (56) 1.18* (42)
a. DZ4717 has the same reversal frequency as wild type (see
Fig. S5).
Asterisks indicate that reversals are statistically the same as DZ4717
(Student’s t-test). Values that were statistically different from DZ4717
had P-values less than 0.005 (Student’s t-test).
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defects. These mutants swarmed less than DfrzCD
(Fig. 4), hyper-reversed compared with DZ4717 (Table 4),
and formed smaller and less dispersed fruiting bodies
than DZ4717 during development (Fig. 3J and L).
The frzCD E168A,E175A and frzCD E168A,E175A,E182A mutants dis-
played phenotypes that were intermediate between
DZ4717 and the hyper-reversing frzCD D6–183 mutant.
Discussion
FrzCD, the principal MCP for the Frz chemosensory
pathway, plays a central role in regulating cellular motility
and behaviour in M. xanthus. Previous studies showed
that methylation of FrzCD by FrzF is critical to function of
FrzCD, as cells lacking FrzF, the unusual TPR domain
containing methyltransferase, rarely reverse and are
unable to swarm, form fruiting bodies, or move towards
nutrients (Blackhart and Zusman, 1985; Bustamante
et al., 2004). We were curious to learn the role of the
TPRs in FrzF and how methylation regulates FrzCD
receptor activity.
By analysing in vitro methylated FrzCD by mass spec-
trometry, we found that FrzF methylates FrzCD on one
residue, E182, and that FrzFCheR methylates FrzCD on
threeresidues,E168,E175andE182.Whenwecompared
the methylated residues of FrzCD with methylated resi-
dues of the E. coli MCP, Tar, we found both similarities and
differences (Fig. 5). Both FrzCD and Tar have methylation
sites spaced seven residues apart. It has been shown that
methylation sites spaced at seven residue intervals are
located on the same face of the a-helix and are accessible
to the methyltransferase (Terwilliger et al., 1986).
Several differences exist between the methylation
sequences of Tar and FrzCD. Tar is methylated on
glutamine (Q) or glutamate (E) residues that are located
within QQ, EE, QE or EQ methylation pairs and methyla-
tion occurs on the second residue of the methylation pair
(Kehry and Dahlquist, 1982; Terwilliger et al., 1983; Terwil-
liger and Koshland, 1984). In FrzCD, only site E182 con-
forms precisely to the E. coli paradigm; it is methylated on
the second residue of an EE methylation pair. Site E175 is
the most unusual of the FrzCD methylation sites; it is not
located in a typical methylation pair. Site E175 is ﬂanked
instead by histidine (H) and threonine (T) residues (Fig. 5).
Thisisonlythesecondinstanceofareceptorbeingmethy-
lated outside of a typical methylation pair. In Thermotoga
maritima, the receptor TM0429c is methylated on the
glutamateinaTEpair(Perezet al.,2006).FrzCDsiteE168
is also somewhat atypical because methylation is occur-
ring on the ﬁrst residue of a methylation pair (Fig. 5).
Although unusual, other receptors have been shown to be
methylated on the ﬁrst residue of a methylation pair (Perez
et al., 2006). We found it interesting that FrzCD site E182,
which conforms precisely to the E. coli consensus
sequence, was methylated by both FrzF and FrzFCheR in
vitro, but that sites E168 and E175, which differ from the
E. coli consensus sequence, were only methylated by
FrzFCheR. It is possible that methylation preferentially
occursonsitesthatadheremorecloselytothemethylation
consensus sequence found in E. coli.
TolearnhowmethylationaffectstheactivityofFrzCDwe
constructed mutations in each of the identiﬁed methylation
sites.Aprevious study had mutated each QQ, EE, EQ and
QE pair in FrzCD to a double AA (Astling et al., 2006).
Because FrzCD sites E168 and E182 were located within
EQ and EE pairs, respectively, the FrzCDE168AQ169A and
FrzCDE181AE182A mutants were constructed, previously.
Astling et al. (2006) found by analysing single cell rever-
sals that the FrzCDE168AQ169A mutant appeared to hyperac-
tivate FrzCD, whereas the FrzCDE181AE182A mutant resulted
in a hypoactive FrzCD signally state. Although these
resultswerepromising,wewereconcernedthatthedouble
AAmutation may result in a more severe phenotype than a
single mutant.Additionally, we identiﬁed a FrzCD methyla-
tion site that was located outside of a QQ, EE, QE, EQ
methylation pair and were interested to learn its function.
We were also interested in learning the phenotype of both
the gain and loss of methylation at each site; therefore, we
constructed mutants where we replaced each methylat-
able glutamate with an alanine to mimic methylation or an
aspartate to mimic demethylation (Nowlin et al., 1987;
Shapiro and Koshland, 1994).
We found that site 182 (the site methylated by both FrzF
and FrzFCheR) displayed the most profound phenotypes of
the single mutants. In fact, the frzCD E182D mutant behaved
similarly to the DfrzCD mutant suggesting that methylation
at this residue is critical for activating the Frz pathway.
Furthermore, the frzCD E182D mutant phenotype also
resembledtheDfrzEandthefrzE H49A(kinasedead)mutant
phenotypes suggesting that FrzCDE182D may inhibit the
histidine kinase activity of FrzE. The severe mutant phe-
166 STEQAAAIHETTATMEEL 184
293 TEQQASALEETAASMEQL 311
+ +QA+A +ET A+ME+L
FrzCD
Tar
295 302 309
168 175 182
Fig. 5. Similarities between the methylation site sequences of
M. xanthus FrzCD and E. coli Tar. The FrzCD peptide containing
identiﬁed methylated residues is shown aligned with a methylated
peptide from the E. coli receptor, Tar. Residues that are identical or
that share similar charges are indicated on the second row by a
letter (amino acid) or ‘+’ respectively. Sites of methylation are
indicated by a box and an arrow. Numbers indicate amno acid
position in FrzCD.
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methylation at other nearby methylation sites. In E. coli,
replacing a methylatable E or Q residue with a D residue
has been shown to prevent methylation at nearby sites
(Shapiro et al., 1995). This appears to hold true for the
frzCD E182D mutant. We do not see any FrzCD methylation
in M. xanthus in the frzCD E182D mutant (Fig. 2). As the
frzCD E182D mutant displayed a more severe phenotype
than either the frzCD E168D,E175D,E182D or frzCD E168D,E175D
mutants, we concluded that the frzCD E182D mutant pheno-
type was not due to loss of methylation at sites E168 or
E175. It is likely that the frzCD E182D mutant lacks methyla-
tion at unidentiﬁed sites. We believe that additional FrzCD
methylation sites exist because the frzCD E168D,E175D,E182D
mutant still displays a methylated band of FrzCD (Fig. 2).
We anticipate that several additional methylation sites
maybeuncoveredwhenglutamineresiduesareconverted
to glutamates by a methylesterase in vivo (Stock and
Koshland, 1978). Additionally, some methylation sites
may only be modiﬁed in vivo under certain physiological
conditions.
Mutations in FrzCD site E175 resulted in less severe
mutant phenotypes compared with mutations in FrzCD
site E182. Strains containing an aspartate or an alanine
at site 175 displayed a decrease in single cell reversal
frequency, but showed no obvious defect in social
swarming or fruiting body development. These results
suggest that site E175 is critical for coordinating single
cell behaviour, but is dispensable for groups of cells.
This is interesting because it suggests that FrzCD is
able to regulate single cell behaviour and social behav-
iour independently.
FrzCD site 168 appears to play a role in regulating
social swarming. The frzCD E168A mutant displayed a
reduction of social swarming, but did not have an obvious
defect in fruiting body formation and single cells reversed
normally. The frzCD E168D mutant did not display any
mutant phenotypes. Thus, site E168 appears to be a
minor regulator of FrzCD when methylated alone.
However, when both FrzCD sites E168 and E175 were
replaced with alanines, M. xanthus cells displayed pro-
found affects; cells were unable to swarm, they were
defective in fruiting body formation, and single cells hyper-
reversed. Thus, simultaneous methylation at these two
sites seems to activate FrzCD. It was interesting that the
frzCD E168D,E175D mutant did not display any mutant
phenotypes. Thus, the mutation at site 168 can rescue the
hypo-reversing phenotype of the frzCD E175D mutant.
In sum, we found that the TPRs of FrzF inhibit its ability
to methylate FrzCD in vitro. Additionally, each site of
FrzCD methylation plays a unique role in regulating
FrzCD activity. Third, FrzCD appears to be able to control
single cell and social behaviours independently. Last, our
results conﬁrm previous work by Astling et al. (2006),
which suggested that FrzCD methylation could both turn
on and off receptor activity and that the pattern of methy-
lation determines the activity of FrzCD, not the quantity of
methylation.
Based on our current knowledge of the Frz pathway, we
have proposed a model that addresses a putative input
into FrzCD, the regulation of FrzCD activity, and how
FrzCD activity regulates downstream signalling and cell
behaviour. We believe that one input into FrzCD can be
the methylation of FrzCD by FrzF. FrzF may be controlled
by its TPRs. As FrzFCheR methylates FrzCD more than
FrzF in vitro, it is possible that the TPRs prevent the
methyltransferase domain from methylating speciﬁc resi-
dues of FrzCD (such as E168 and E175) by forming a
physical barrier between the methyltransferase domain
and certain binding sites on FrzCD. To relieve this inhibi-
tion, the TPRs may bind to another protein. This binding
may place the TPRs in a conformation in which they
no longer impede the methyltransferase domain, thus
allowing FrzF to methylate additional FrzCD residues.
We hypothesize that a FrzF TPR-binding partner is
up-regulated or activated as cells proceed through devel-
opment because FrzCD methylation has been shown to
increase as M. xanthus cells develop (McBride and
Zusman, 1993). Additionally, we propose that the TPR-
binding partner is upregulated by AsgA, CsgA, FruA and
DevT and downregulated by RodK because FrzCD
methylation is reduced in asgA, csgA, fruA and devT
mutants, and increased in rodK mutants (Sogaard-
Andersen and Kaiser, 1996; Geng et al., 1998; Boysen
et al., 2002; Rasmussen et al., 2005).
The second part of our model explains how the activity
of FrzCD can be controlled through methylation. We
propose that methylation can both turn on and turn off
FrzCD activity. For instance, if FrzCD is methylated on
one site (E182) its activity is inhibited, whereas if it is
methylated on additional residues (E168 and E175) its
activity is activated. These hypotheses are based on our
FrzCD methylation point mutant data where mutations in
site E182 were similar to a deletion of FrzCD and muta-
tions that mimicked methylation at both 168 and 175
resembled a ‘hyperactive’ frzCD mutant (frzCD D6-183).
The ﬁnal part of our model involves how FrzCD activity
regulates downstream proteins. It has been proposed that
the CheA homologue, FrzE, stimulates cellular reversals
by autophosphorylating and transferring a phosphoryl
group to the dual receiver domain containing protein, FrzZ
(McCleary and Zusman, 1990; Inclán et al., 2007). We
propose that certain methylation sites lead to an active
form of FrzCD and this stimulates FrzE kinase activity,
which leads to an increase in cellular reversals. Con-
versely, methylation states of FrzCD that inhibit activity
result in a reduction of FrzE kinase activity and a reduc-
tion in cellular reversals.
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Bacterial strains and culture conditions
The strains used in this study are listed in Table 5. M. xanthus
was grown in CYE medium, which contains 10 mM morpho-
linepropanesulphonic acid (MOPs, pH 7.6), 1% (w/v) Bacto
Casitone (BD Biosciences), 0.5% Bacto yeast extract and
4 mM MgSO4 (Campos et al., 1978). For M. xanthus swarm-
ing phenotypes 5 ml of cells at 4 ¥ 10
9 cells ml
-1 were spotted
on CYE plates containing 0.5% Bacto agar (BD Biosciences).
For developmental phenotypes 5 ml of cells at 2 ¥ 10
9
cells ml
-1 were spotted on CF agar which contains 1.5%
Bacto agar, 10 mM MOPs (pH 7.6), 0.015% Bacto Casitone,
8 mM MgSO4, 1 mM KH2PO4, 0.02% NH4SO4, 0.2% sodium
citrate and 0.1% pyruvate (Hagen et al., 1978).
Reversal frequency analysis
Cells were grown to mid-log phase and 10 ml of culture were
spotted on 1/2 CTT (Hodgkin and Kaiser, 1977) with 1.5%
agar. The cells were covered immediately with an oxygen
permeable membrane (Yellow Springs Instrument) and
allowed to settle for 1 h. Cells were ﬁlmed using a Labophot
2 microscope and a micropublisher 3.3 RTV digital camera (Q
imaging) and reversal frequencies were analysed by eye.
Only moving cells that did not touch another cell during
ﬁlming were analysed. A students t-test (two-tailed, type 3)
was used to determine if the reversal frequency of each strain
differed from wild type. Strains with a P-value less than 0.005
were considered to have different reversal frequencies from
wild type. For each strain, a minimum of ﬁve movies were
taken on two separate days.
Protein puriﬁcation from E. coli
To obtain soluble protein, frzF and frzF
cheR ampliﬁed by PCR
fromgenomicDNAandinsertedintopET28a(Novagen)atthe
EcoRI and HindIII sites. The plasmid was sequenced and
analysed using the Sequencher program (Gene Codes) and
transformed into the E. coli Tuner protein expression strain
(Novagen). Cells were grown to mid-log phase at 37°C and
expression was induced by adding 1 mM of IPTG and trans-
ferring cells to 18°C for 16 h. Cells were isolated by centrifu-
gation at 9000 g. Cells were lysed by sonication (Branson
soniﬁer450)(3 ¥ 1 minoutput4)in20 mMTrispH 7.2,20 mM
imidizole, 10% glycerol, 0.1% CHAPS buffer, 500 mM NaCl
lysis buffer supplemented with 2% mammalian protease
inhibitor cocktail (Sigma). Insoluble material was removed by
centrifugation (20 min, 17 000 g) and ﬁltration through a 0.22
micron ﬁlter (Corning 115 ml ﬁlter system). Cell lysate was
injected onto a 5 ml HisTrap HP Nickel column (GE Health-
care)viaanAKTAFPLC(GEHealthcare).Proteinwaswashed
with 50 ml of lysis buffer, then 50 ml of lysis buffer with 60 mM,
100 mMand150 mMimidizole.FrzF
CheRwaselutedusinglysis
buffer with 250 mM imidizole. The protein was concentrated
using 30 000 molecular weight cutoff Centriprep columns
(Amicon).
In vitro methylation of FrzCD
Each FrzCD methylation reaction mixture contained 3.5 mM
FrzCD, 6 mM SAM, 7 mM FrzF or FrzF
CheR, 10 mM TrisHCl
pH 7.0, 1% glycerol and 50 mM KCl. Reactions took place at
32°C for 4 h. FrzCD methylation was observed initially by
SDS-PAGE analysis and then by Mass Spectrometry
(see below). Each reaction was repeated in triplicate on four
separate days.
Sample preparation for mass spectrometry
Methylation of receptors was performed as described above.
Methylated and unmethylated species were separated by
SDS-PAGE. Gels were stained with Coloidal Coomassie
(Invitrogen) and bands corresponding to unmethylated and
methylated FrzCD were excised and diced into ~1–2 mm
3
pieces. The gel slices were destained twice by incubation
with 50 ml of 100 mM ammonium bicarbonate and 50 mlo f
acetonitrile at 37°C for 10 min The gel slices were then dehy-
drated by incubation with 50 ml of acetonitrile at 37°C for
5 min. FrzCD contains no cysteine residues, so reduction and
alkylation were not performed. Gel slices were incubated
overnight at 37°C in 50 ml of 100 mM ammonium bicarbonate
containing 150 ng of trypsin (Promega), chymotrypsin
(Roche) or GluC (Roche). Peptides were extracted from the
gel slices by incubation with 30 ml of extraction solution (2%
acetonitrile and 1% formic acid) at 37°C for 30 min. The
solution was removed and a second extraction was per-
formed with 12 ml of acetonitrile and 12 ml of extraction solu-
tion at 37°C for 30 min. The peptide extract was dried down
and reconstituted in 25 ml of 0.1% triﬂuoroacetic acid (TFA).
Liquid chromatography/mass spectrometry
High-performance liquid chromatography grade water and
acetonitrile (Optima) and formic acid (Acros Organics) were
purchased from Fisher Scientiﬁc. TFA was purchased from
Sigma-Aldrich. Peptides were desalted and concentrated on
a reversed-phase cartridge (Zorbax C18; 5 mm by 0.3 mm i.d.;
5 mm; Agilent) then loaded onto a reverse-phase column
(ProteoPep
TM C18, 5 cm by 50 mm i.d.; 300 Å; 5 mm; New
Objective) using an Ultimate
TM nanoliquid chromatography
system (Dionex/LC Packings) coupled to a ThermoFinnigan
Orbitrap tandem mass spectrometer equipped with a nano-
spray source (Michrom Bioresources). The column was
equilibrated for 5 min in 94% solventA(0.1% formic acid) and
6% solvent B (90% acetonitrile, 0.1% formic acid). Solvent B
was increased linearly to 40% at 40 min, 60% at 45 min and
100% B at 45.1 min, where it was held for 3 min. It was then
set back to its initial solvent composition (6% B), where it was
held for the duration of the run (60 min). MS survey scans
were performed in the orbitrap followed by subsequent
MS/MS scans of the three most abundant ions fragmented in
the linear ion trap, with a dynamic exclusion of 30 s. Data ﬁles
(.dta) for MS/MS spectra were generated by Bioworks
Browser 3.2 EFI software (Thermo Fisher Scientiﬁc), con-
verted to MASCOT generic format (.mgf), and searched
against a proteomic database for M. xanthus. Peptides iden-
tiﬁed by MASCOT, with or without methyl modiﬁcations, at a
signiﬁcance score above 95% conﬁdence, were validated
manually. No ﬁxed modiﬁcations were used in the searches
while methionine oxidation, asparagine and glutamine dea-
midation, and aspartate and glutamate methylation were
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sample were analysed.
Construction of mutants
All strains and plasmids are listed in Table 5. Point mutations
were made using PCR. M. xanthus genomic DNA from strain
DZ2 was used as a template for PCR. Oligonucleotides were
prepared by operon. Complementary forward and reverse
primers were used to amplify the gene with platinum HiFi Taq
(Invitrogen). The primers for the coding strand are listed
below with the lower case indicating the altered codon:
For frzCD
E168D catgagacgtcctccacggaccaggcggcggccatc
cacg, For frzCD
E168A catgagacgtcctccacggcgcaggcggcg
gccatccacg, For frzCD
E175D caggcggcggccatccacgacacgacc
gccaccatggaggag, For frzCD
E175A caggcggcggccatccacgcg
acgaccgccaccatggaggag, For frzCD
E182D Cacgagacgaccgcc
accatggaggacctgaagcacgcgtcggcgc, For frzCD
E182A CACC
ATGGAGgcgctgaagcacgc. For frzCD
E168D E175D we used
pAS215 as template and primer catgagacgtcctccacggaccag
gcggcggccatccacg, For frzCD
E168A E175A we used pAS212 and
primer catgagacgtcctccacggcgcaggcggcggccatccacg, For
frzCD
E168D E175D E182D we used pAS218 as template and primer
cacgagacgaccgccaccatggaggacctgaagcacgcgtcggcgc, For
frzCD
E168A E175A E182A
we used pAS217 (E168A E174A) and
primer CACCATGGAGgcgCTGAAGCACGC.
Once each half of the insert was constructed the two PCR
products per mutant were used as template and the primers.
GATATCCAGCTGCCCGAGGAGGACGATG and GGCCAGT
GCCAAGCTTCATTACTAGTCG were used to construct the
complete insert. The insert was then placed into the digested
(SmaI and HindIII) pCT2 (Mignot et al., 2007) plasmid via the
In-Fusion reaction (Clonetech). The resulting plasmids were
conﬁrmed by DNA sequencing.
Plasmids containing the wild-type frzCD and the point
mutations were inserted into the crtB locus of M. xanthus
strain DfrzCD and conﬁrmed by PCR and sequencing. In all
ﬁgures ‘wild type’ corresponds to 6His::frzCD in the crtB
locus. To induce expression of frzCD and the point mutants,
50 mgm l
-1 of anhydrotetracycline HCl (Reidel-de Haen) was
used in all media.
Immunoblot analysis of FrzCD
Myxococcus xanthus strains were grown to mid-exponential
phase, concentrated by centrifugation, and resuspended in
1 ¥ SDS loading buffer lacking coloured dye. Cells were lysed
by 10 s of sonication (Branson soniﬁer 450) on ice. Protein
concentration was determined using the BCA (bicinchoninic
acid) method (reagents from Pierce). Cells were resus-
pended to the same concentration in 2 ¥ SDS loading buffer.
Thirty micrograms of total protein were loaded per lane on
Table 5. Strains and plasmids used in this study.
Strain or plasmid Relevant feature Source
M. xanthus
DZ2 Wild type Laboratory collection
VB197b frzCD
D6-183 Bustamante et al. (2004)
DZ4480 DfrzCD Bustamante et al. (2004)
DZ4717 DfrzCD, 6His::frzCD integrated in crtB This study
DZ4707 DfrzCD 6His::frzCD
E168A integrated in crtB This study
DZ4708 DfrzCD 6His::frzCD
E175A integrated in crtB This study
DZ4709 DfrzCD 6His::frzCD
E182A integrated in crtB This study
DZ4710 DfrzCD 6His::frzCD
E168D integrated in crtB This study
DZ4711 DfrzCD 6His::frzCD
E175D integrated in crtB This study
DZ4712 DfrzCD 6His::frzCD
E182D integrated in crtB This study
DZ4713 DfrzCD 6His::frzCD
E168A E175A integrated in crtB This study
DZ4714 DfrzCD 6His::frzCD
E168D E175D integrated in crtB This study
DZ4718 DfrzCD 6His::frzCD
E168A E175A E182A integrated in crtB This study
DZ4719 DfrzCD 6His::frzCD
E168D E175D 182D integrated in crtB This study
E. coli
Top10 General cloning strain Invitrogen
Tuner Protein expression strain Novagen
Plasmids
pET28a Expression plasmid Novagen
pAS201 pET28a with 6His::frzF
cheR This study
pCT2 M. xanthus genomic integration plasmid Mignot et al. (2007b)
pAS210 pCT2 with 6His::FrzCD This study
pAS211 pCT2 with 6His::frzCD
E168A This study
pAS212 pCT2 with 6His::frzCD
E175A This study
pAS213 pCT2 with 6His::frzCD
E182A This study
pAS214 pCT2 with 6His::frzCD
E168D This study
pAS215 pCT2 with 6His::frzCD
E175D This study
pAS216 pCT2 with 6His::frzCD
E182D This study
pAS217 pCT2 with 6His::frzCD
E168A E175A This study
pAS218 pCT2 with 6His::frzCD
E168D E175D This study
pAS221 pCT2 with 6His::frzCD
E168A E175A E182A This study
pAS222 pCT2 with 6His::frzCD
E168D E175D E182D This study
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gel was transferred to a nitrocellulose membrane. Blots were
probed with anti-FrzCD antibody as described (McCleary
et al., 1990) and with the antirabbit alexa ﬂuor 680 (Molecular
Probes) secondary antibody. Blots were visualized using an
infrared imaging system (LiCor) and results were analysed
using Odyssey software. The data were conﬁrmed by three
independent experiments done in duplicate.
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